Latest filing published 15 Oct 2025 for The Biotech Growth Trust PLC, €4,553.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +19.7%Entry £10.65 · Close at T+90 £12.75
- +34.2%Entry £9.39 · Close at T+365 £12.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Julie Tankard: trading record in brief
Julie Tankard is a declared insider of The Biotech Growth Trust PLC, with filings sourced from RNS (LSE). The record holds 2 filings, for trades running from 4 December 2024 to 15 October 2025.
The open-market record is one-sided, with 2 purchases worth €17k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2025 alone, the filings show 1 purchase and no sales.
On 15 October 2025 came the latest disclosure, an open-market purchase for €4,553 in The Biotech Growth Trust PLC. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to Julie Tankard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 369 shares@ £10.720827.5% of flowLondon Stock Exchange (XLON)ISIN GB0000385517RNS:202510151017PR_NEWS_UKDISCLO_0105Canonical exit: 13 Jan 2026 (T+90)
- 1,022 shares@ £9.724572.5% of flowLondon Stock Exchange (XLON)ISIN GB0000385517RNS:202412041137PR_NEWS_UKDISCLO_0102Canonical exit: 4 Mar 2025 (T+90)
2 of 2 declarations